Results 171 to 180 of about 8,852 (197)

Corneal pseudomicrocysts following claudin-6 antibody-drug conjugate infusion. [PDF]

Am J Ophthalmol Case Rep
Matuszewska L, Cooper C, Sattarova V, Chanbour W, Meyer E, Rashidi V.   +5 more
europepmc   +1 more source

Impact of Antiglaucoma Drug Number and Class on Corneal Epithelial Thickness Measured by OCT. [PDF]

Pharmaceuticals (Basel)
Miklaszewski P, Gadamer AM, Janiszewska-Bil D, Lyssek-Boroń A, Dobrowolski D, Wylęgała E, Grabarek BO, Koss MJ, Krysik K.   +8 more
europepmc   +1 more source

Iris cerclage with goniosynechialysis and canalicular stent for neovascular angle closure glaucoma. [PDF]

Am J Ophthalmol Case Rep
Mahjabin F, Libre PE.
europepmc   +1 more source

Topical medications for moderate-to-severe rosacea: protocol for a living systematic review and network meta-analysis. [PDF]

BMJ Open
Amstutz AV, Fladger A, Sanchez-Feliciano A, Barbieri JS.   +3 more
europepmc   +1 more source

Vision related quality of life and topical glaucoma treatment side effects [PDF]

core   +1 more source

Engineered Multifunctional Drug-Loaded Dendrimer Nanoparticles for Glaucoma: Triple Mechanism via Antioxidant Activity, Iron Chelation, and Enhanced Ocular Transport. [PDF]

Biomacromolecules
Ates B, Trital A, Mani VJ, Xu L, Kenlee J, Ercal N, Yang H.   +6 more
europepmc   +1 more source

Pseudohypopyon in a Child With Elevated Intraocular Pressure and Progressive Deterioration of Visual Acuity. [PDF]

Cureus
Miershali M, Gill GS, Obulkasim M, Bains H, Sanghvi HA.   +4 more
europepmc   +1 more source

Targeting Vascular and Inflammatory Crosstalk: Cannabigerol as a Dual-Pathway Modulator in Rosacea. [PDF]

Int J Mol Sci
Kim S, Lee JH.
europepmc   +1 more source

Neuroprotection in glaucoma – what is the role of brimonidine?

Marta Misiuk‐Hojło, Małgorzata Mimier-Janczak   +1 more
openalex   +2 more sources

Randomized Clinical Trial of Intraocular Pressure-Lowering Medications on Preventing Spikes in Intraocular Pressure Following Intravitreal Anti-Vascular Endothelial Growth Factor Injections. [PDF]

Ophthalmol Ther
Soomsawasdi P, Rojananuangnit K, Arayangkoon E, Chantiwas R, Pengrungreungwong S, Preawsampran N, Tinpowong N, Samakhararaksakul R, Katkingkaew K, Seekhum N, Sathim W.   +10 more
europepmc   +1 more source